The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid

Journal of Periodontology

Volumn 67, Issue 9, 1996, Pages 866-870

  Pourtaghi, N ^a   Radvar, M ^a   Mooney, J ^a   Kinane, D F ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

antimicrobial therapy; metalloproteinases; periodontal diseases microbiology; periodontal diseases pathogenesis; periodontal diseases therapy

Indexed keywords

ANTIBIOTIC AGENT; METRONIDAZOLE; MINOCYCLINE; STROMELYSIN; TETRACYCLINE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GINGIVITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIODONTAL DISEASE; RANDOMIZED CONTROLLED TRIAL;

EID: 0029770472     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1996.67.9.866     Document Type: Article

References (33)

1. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64:474-484.
2. Lee W, Aitken S, Kulkarni G, Birek P, Overall CM, Sodek J, McCulloch CA. Collagenase activity in recurrent periodontitis: Relationship to disease progression and doxycycline therapy. J Periodont Res 1991;26:479-485.
3. Meikle MC, Atkinson SJ, Ward RV, Murphy G, Reynolds JJ. Gingival fibroblasts degrade type I collagen films when stimulated with tumour necrosis factor and interleukin 1: Evidence that breakdown is mediated by metalloproteinases. J Periodont Res 1989;24:207-213.
4. Ingman T, Sorsa T, Michaelis J, Konttinen YT. Matrix metalloproteinases-1, 3, 8 in adult periodontitis in situ. Ann NY Acad Sci 1994;732:459-461.
5. Murphy G, Koklitis P, Carne AF. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complex yields fully active inhibitor. Biochem J 1989;261:1031-1034.
6. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
7. Larivee L, Sodek J, Ferrier JM. Collagenase and collagenase inhibitor activities in crevicular fluid of patients receiving treatment for localized juvenile periodontilis. J Periodont Res 1986;21:702-715.
8. Hakkarainen K, Uitto VJ, Ainamo J. Collagenase activity and protein content of sulcular fluid after scaling and occlusal adjustment of teeth with deep periodontal pockets. J Periodont Res 1988;23: 204-210.
9. Yanagimura M, Koike F, Hara K. Collagenase activity in gingival crevicular fluid and inhibition by tetracyclines. J Dent Res 1989;68: (Spec Issue):1691-1693.
10. Haerian A, Adonogianaki E, Mooney J, Manos A, Kinane DF. Effect of treatment on gingival crevicular collagenase, stromelysin and tissue inhibitor of metalloproteinases and their ability to predict response to treatment. J Clin Periodontol 1996;23:83-91.
11. Haerian A, Adonogianaki E, Mooney J, Docherty JP, Kinane DF. Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites. J Clin Periodontol 1995;22:505-509.
12. Golub LM, Wolff M, Lee HM, et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodont Res 1985;20:12-23.
13. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991;2:297-321.
14. Golub LM, Evans RT, McNamara TF, Lee HM, Ramamurthy NS. A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats. Ann NY Acad Sci 1994;732:96-111.
15. Sorsa T, Ding Y, Salo T, et al. Effects of tetracyclines in neutrophil, gingival, and salivary collagenases: A function and Western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann NY Acad Sci 1994;732:112-131.
16. Suomalainen K, Sorsa T, Golub LM, et al. Specificity of the anticollagenase action of tetracyclines: Relevance to their anti-inflammatory potential. Antimicrob Agents Chemother 1992;36:227-229.
17. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:112-135.
18. Lobene RR, Weatherford T, Ross NM, Lamm RA, Manaker L. A modified gingival index for use in clinical trials. Clin Prev Dent 1986;8:3-6.
19. Griffith GS, Curtis MA, Wilton JMA. Selection of a filter paper with optimum properties for the collection of gingival crevicular fluid. J Periodont Res 1988;23:33-38.
20. Gustafsson A, Asman B, Bergstrom K, Soder PO. Granulocyte elastase in gingival crevicular fluid. A possible discriminator between gingivitis and periodontitis. J Clin Periodontol 1992;19:535-540.
21. Cooksley S, Hipkiss JB, Tickle SP, et al. Immunoassay for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complex. Matrix 1991;109:285-291.
22. Brown RA, Swanson-Beck J. Statistics on microcomputers: A non-algebraic guide to their appropriate use in biomedical research and pathology practice. 3. Analysis of variance and distribution-free methods. J Clin Pathol 1988;41:1256-1262.
23. Radvar M, Pourtaghi N, Kinane DF. Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets. J Periodontol 1996;67:860-865.
24. Golub LM, McNamara TF, D'Angelo GD, Greenwald RA, Ramamurthy NS. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987;66:1310-1314.
25. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF. Low dose doxycycline therapy: Effect on gingival crevicular fluid collagenase activity in humans. J Periodont Res 1990;25:321-330.
26. Loesche WJ, Syed SA, Morrision EO, Kerry GA, Higgins T, Stoll J. Metronidazole in periodontitis I. Clinical and bacteriological result after 15 to 30 weeks. J Periodontol 1984;55:325-335.
27. Teng YT, Sodek J, McCulloch CA. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Periodont Res 1992;27:544-552.
28. Rifkin BR, Vernillo AT, Golub LM. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: A potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol 1993;64:819-827.
29. Uitto VJ, Firth JD, Pan YM, Nip L, Golub LM. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gen expression in human skin keratinocytes. Ann NY Acad Sci 1994;732: 140-151.
30. Sorsa T, Lindy O, Konttinen TY, et al. Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob Agents Chemother 1993;37:592-594.
31. Cawston TE, Murphy G, Mercer E, Galloway WA, Hazieman BL, Reynolds JJ. The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitions. Biochem J 1983;211:313-318.
32. Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 1994;732:31-41.
33. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72-and 92-KDa gelatinases by tissue inhibitor of Metalloproteinases-2. J Biolog Chem 1991;266:13070-13075.